Key Metrics
Price Performance
30-DAY PRICE CHART
1-YEAR PERFORMANCE
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Novo Nordisk A/S is currently trading at $46.60, which is 27.4% below its 52-week high. With a beta of 0.34, the stock shows lower sensitivity to market movements.
Frequently Asked Questions
Is NVO a good buy right now?
Novo Nordisk A/S trades at 11.4x earnings. This is below market average, potentially undervalued. Current risk level is High based on 30.8% volatility.
Does NVO pay dividends?
Yes, Novo Nordisk A/S offers a dividend yield of 3.78%. This translates to approximately $1.76 per share annually.
How volatile is NVO?
With 30-day annualized volatility of 30.8% and beta of 0.34,NVO is classified as High risk. The stock tends to be more stable than the market average.
Related Assets
Track NVO Live
Add Novo Nordisk A/S to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALIMPORT BROKER FILE